Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.
J Eur Acad Dermatol Venereol
; 31(10): 1700-1708, 2017 Oct.
Article
em En
| MEDLINE
| ID: mdl-28485816
ABSTRACT
BACKGROUND:
Little is known about the adverse events (AEs) that lead to suspension of systemic treatments for psoriasis in clinical practice.OBJECTIVE:
The study aimed to investigate AEs associated with discontinuation of systemic therapy in patients with psoriasis in a clinical setting (Biobadaderm). MATERIALS ANDMETHODS:
Multicentre, prospective, cohort study of patients with moderate-to-severe plaque psoriasis receiving systemic therapies from January 2008 to November 2015, in 12 hospitals in Spain. The incidence rate (IR) was used to compare biologics and classic systemic therapies.RESULTS:
A total of 4218 courses of treatment were given to 1938 patients. A total of 447 (11%) treatments were discontinued due to AEs. The IR of AE associated with discontinuation of systemic therapies was 13 events/100 patient-years (PY) (95% CI 12.14-13.93), 9.34 events/100 PY (95% CI 8.44-10.33) for biologics and 19.67 (95% CI 17.9-21.6) events/100 PY for classics (P < 0.001). Of 810 discontinuation-related AEs, 117 (14%) were serious. The highest IRs were for cyclosporine [49.18/100 PY (95% CI 41.91-57.72)] and infliximab [26.52/100 PY (95% CI 20.98-33.51). Ustekinumab presented the lowest IR (2.6/100 PY (95% CI 1.83-3.69).LIMITATIONS:
Observational study with potential selection bias.CONCLUSION:
Biologic therapies are associated with a lower rate of discontinuation-related AEs than are classic therapies in real clinical practice. Ustekinumab showed the lowest incidence.
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Psoríase
/
Síndrome de Abstinência a Substâncias
/
Produtos Biológicos
/
Fármacos Dermatológicos
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Europa
Idioma:
En
Revista:
J Eur Acad Dermatol Venereol
Assunto da revista:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Espanha